Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 3,262

Document Document Title
WO/2013/109929A1
The invention provides methods for production of gangliosides, e.g., GM1, from cells in culture using, for example, bone marrow cells and neuroblastoma cells. Methods include the treatment of cells with neural induction media and chloroq...  
WO/2013/107948A1
The present invention relates to a method for preprocessing lignocellulosic biomass, include: a) a step for the acid hydrolysis of the biomass using an acid solution so as to obtain a liquid fraction and a solid fraction; a step of separ...  
WO/2013/101403A1
Compositions comprising C5 and C6 saccharides of varying degrees of polymerization and low levels of undesirable impurities, such as compounds containing sulfur, nitrogen, or metals, are disclosed.  
WO/2013/101398A1
Compositions comprising C5 and C6 monosaccharides and low levels of undesirable impurities, such as compounds containing sulfur, nitrogen, or metals, are disclosed.  
WO/2013/101314A1
Aspects of the invention provide compositions for use in the treatment galectin- dependent diseases. In particular, compositions comprising a selectively depolymerized, branched galactoarabino-rhamnogalacturonate whose backbone is predom...  
WO/2013/097012A1
The present invention relates to a method for computationally designing new compounds that can potentially function as inhibitors of the endopolygalacturonase enzyme involved in plant-cell-invasion processes. Notably, one of the main use...  
WO/2013/101399A1
Compositions comprising C5 and C6 monosaccharides and low levels of undesirable impurities, such as compounds containing sulfur, nitrogen, or metals, are disclosed.  
WO/2013/101402A1
Compositions comprising C5 and C6 saccharides of varying degrees of polymerization and low levels of undesirable impurities, such as compounds containing sulfur, nitrogen, or metals, are disclosed.  
WO/2013/091621A2
The invention relates to a method for the acid catalysed oligomerisation of monosaccharides and/or disaccharides, in which monosaccharides or disaccharides are subjected to a mechanical treatment in the presence of an inorganic and/or or...  
WO/2013/081294A1
The present invention relates to a processed food composition containing, as an active ingredient, psicose, which is a saccharide having the function of stimulating a daidzein conversion into equol by an intestinal microorganism in the h...  
WO/2013/079819A1
A method for preparing ketose sugars, characterised in that: 1/ at least one aldose sugar or a solution or a suspension of said sugar in water is solubilised, in at least one organic solvent; 2/ the organic solution obtained is brought i...  
WO/2013/066941A1
In one aspect, catalytic membranes are described herein. In some embodiments, a catalytic membrane comprises a surface functionalized with a polymer, the polymer comprising cellulose solubilization functionalities and acid functionalitie...  
WO/2013/059523A2
The present disclosure relates carbonaceous materials and to methods of using such carbonaceous materials for purifying oligomers produced from depolymerized biomass, such as lignocellulosic biomass.  
WO/2013/046180A1
A method that can be used to make a precursor of L-fiicose from D-glucose, that comprises the steps of: a) making a compound of formula (1) from D-glucose, formula (1) wherein R1 is acyloxy, and Q is a group (a), (b), (c) or (d), Formula...  
WO/2013/046181A1
The present invention provides a process for converting D-glucose into L-fucose, where a first aspect of the invention relates to a method of making a compound of formula (1) wherein R is independently H,alkyl or phenyl or, preferably, w...  
WO/2013/042587A1
Provided is a production method whereby it is possible to produce a powder containing crystalline trehalose dihydrate with starch as a starting material with high powder-to-starch yields. More specifically, provided is a production metho...  
WO/2013/036286A2
The present invention discloses certain polyene cyclodextrin acetals and hemiacetals that are effective in providing skin clarification, which is useful for the treatment of acne, and skin disfigurements and skin darkening resulting from...  
WO/2013/035479A1
[Problem] To provide a composition for improving an in vivo metabolism parameter. [Solution] A composition containing D-psicose as an active ingredient, which can be used for giving D-psicose at a dose of 5 g or more for each time contin...  
WO/2013/026842A1
The present invention is directed towards new 18F-folate radiopharmaceuticals, wherein the 18Fisotope is linked via a prosthetic group, more specifically via a prosthetic group having a saccharide group, such as acyclic mono-or oligosacc...  
WO/2013/026275A1
Provided in the present invention is a process for extracting L-arabinose from a xylose mother liquid, comprising the procedures of the fermentation, purification, and concentration of a xylose mother liquid, crystallizing the concentrat...  
WO/2009/134816A9
Biomass (e.g., plant biomass, animal biomass, and municipal waste biomass) is processed to produce useful products, such as fuels. For example, systems can use feedstock materials, such as cellulosic and/or lignocellulosic materials, to ...  
WO/2013/017254A1
The invention relates to a synthetic oligosaccharide representing part of the repeating unit of the Clostridium difficile glycopolymer PS-I and having the sequence of the pentasaccharide a-L-Rhap- ( 1→3 ) -β-D-Glcp- ( 1→4 ) - [a-L-R...  
WO/2013/014565A1
The disclosures herein provide compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. These salts may be formulated as pharmaceutical compositions....  
WO/2013/011460A1
The present invention relates to process for the preparation and purification of 4-O-β-D-glucopyranosyl-1,6-anhydro-β-D-glucopyranose represented by Formula (II). The process of the invention can be used in the production of fondaparin...  
WO/2013/011216A1
The present invention relates to a boiled sugar sweet comprising a mixture of sugars consisting of glucose and of non-fructosylated α-galactooligosaccharides in particular proportions. The subject matter of the present invention is also...  
WO/2013/013244A2
The present invention provides a one-pot, multi-enzyme method for preparing UDP-sugars from simple sugar starting materials. The invention also provides a one-pot, multi-enzyme method for preparing oligosaccharides from simple sugar star...  
WO/2013/006906A1
There is provided methods for the enrichment, isolation and/or modification of the dermatan sulphate (DS) derived from sources including hide processing waste streams. There is also provided uses of dermatan sulphate and/or low molecular...  
WO/2013/008699A1
Provided is a method for manufacturing water-soluble saccharides in which a polysaccharide can easily be decomposed into water-soluble saccharides. This method manufactures water-soluble saccharides from a substance for treatment that co...  
WO/2012/177839A1
The present invention discloses diblock copolymer systems that self-assemble to produce very small structures. These co-polymers consist of one block that contains silicon and another block comprised of an oligosaccharide that are couple...  
WO/2012/171966A1
The present invention relates to a method for the preparation of disaccharides and polysaccharides by means of the regioselective hydrolysis of monosaccharide units in the primary position.  
WO/2012/156750A1
A glycoconjugate for use in treating or preventing an HIV infection or AIDS, wherein the glycoconjugate comprises an oligosaccharide group which is linked to a carrier protein, wherein the oligosaccharide group is of formula (I): wherein...  
WO/2012/158517A1
The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.  
WO/2012/156273A1
A method for the manufacture an infant formula or an infant nutritional product comprising mixture of human milk oligosaccharides is disclosed. The method involves the catalytic hydrogenolysis of compounds of the general formula 1 and 2 ...  
WO/2012/156898A1
A method of diversification of human milk oligosaccharides (HMOs) or precursors thereof, compounds obtainable by the method, and uses and compositions involving such compounds. The method comprises the steps of a) providing at least one ...  
WO/2012/152120A1
Disclosed are a metabolite comprising L-arabinose and the method for producing the same. The solid contents of the said metabolite comprise weight percent of xylose 20%-90%, L-arabinose 10%-80%, galactose 0%-15% and dextrose 0%-15%.  
WO/2012/151531A2
Methods are disclosed for increasing the level of C5 monosaccharides produced from lignocellulosic biomass using a multistage fractionation process to handle recalcitrant C5 oligosaccharides without producing unwanted degradation product...  
WO/2012/151526A2
Methods are disclosed for increasing the level of soluble C5 saccharides produced from lignocellulosic biomass comprising acidifying fractionated lignocellulosic biomass to prevent the recondensation of soluble C5 saccharides, including ...  
WO/2012/151536A2
Methods are disclosed for controlling the rate of cellulose hydrolysis and reducing the rate of glucose degradation by adjusting the pH during cellulose hydrolysis.  
WO/2012/151521A2
Methods are disclosed for increasing the yields of fermentable C6 sugars from lignocellulosic biomass by using a multistage cellulose hydrolysis and quench, with or without acid.  
WO/2012/147705A1
[Problem] The purpose of the present invention is to provide a therapeutic agent for inflammatory respiratory diseases, which has excellent biocompatibility. [Solution] The present invention is achieved essentially on the basis of workin...  
WO/2012/141523A2
The present invention relates to a supported catalyst for preparing sugar alcohols by means of the catalytic hydrogenation of sugar, to a method for preparing the supported catalyst, and to a method for preparing sugar alcohols using the...  
WO/2012/142615A2
Auranofin analogs and pharmaceutical compositions which inhibit p-STAT3 are provided together methods of synthesizing and methods of using the compounds. Also provided are methods of treating p-STAT3 diseases and disorders in a patient i...  
WO/2012/113405A1
A method for the manufacture of a mixture of human milk oligosaccharides is disclosed. The method involves the catalytic hydrogenolysis of compounds of the general formula 1 and 2. The use of compounds of general formula 1 and 2 in the m...  
WO/2012/116196A2
The invention provides methods for producing compounds comprising a substitution at the 1'-position of a lactosyl ring. Also provided are compounds having a radionuclide, such as 18F substituted at the 1'-position of a lactosyl ring. Com...  
WO/2012/111794A1
A method for producing a sugar solution by processing a cellulose-derived sugar solution with use of one or more separation membranes selected from among an ultrafiltration membrane, a nanofiltration membrane and a reverse osmosis membra...  
WO/2012/108293A1
The purpose of the present invention is to provide a method for producing a solid matter from a saccharide solution containing isomaltulose. A method wherein a sucrose solution is treated with an enzyme, which is capable of synthesizing ...  
WO/2012/097052A2
The present invention relates to compounds and methods which may be useful as inhibitors of glycolysis, inhibitors of protein glycosylation, anti-virals, and down-regulators of insulin receptor and IGF- 1 receptor for the treatment or pr...  
WO/2012/093564A1
[Problem] To provide a method for producing an inexpensive sugar condensate that can be used in food and drink products. [Solution] A method for producing a sugar condensate, characterized in that a sugar condensation reaction is perform...  
WO/2012/076934A1
The present invention relates to a calixarene-based glycosylated compound (I) having the formula : (I) wherein D is independently selected in the group comprising a –CH2 –group, an oxygen atom, a sulphur atom, a sulfinyl group or a s...  
WO/2012/077828A1
The purpose of the present invention is to provide a prophylactic or therapeutic agent for inflammatory diseases, which can inhibit the function of an inflammatory cytokine and therefore can exhibit an anti-inflammatory effect. The prese...  

Matches 401 - 450 out of 3,262